UN health agency ‘strongly recommends’ DTG antiretroviral drug to manage HIV/AIDS

Geneva, Switzerland (PANA) - Based on new evidence, the United Nations health agency on Monday announced it was recommending the use of the antiretroviral drug dolutegravir (DTG) – which, with other medication, treats HIV/AIDS – as the preferred first- and second-line treatment for all cases, including pregnant women and those who have the potential to give birth